About this trial

To evaluate the blood pressure lowering effects of thiazide diuretics in patients on peritoneal dialysis

Eligibility criteria

Qualifiers

Patients on chronic peritoneal dialysis, with uncontrolled hypertension (SBP >140 mmHg and/or DBP >90 mmHg)

Disqualifiers

Patients with a life expectancy of less than 3 months, planned conversion to hemodialysis, or scheduled kidney transplantation within 3 months

Trial design

Treatments tested in this trial

  • Hydrochlorothiazide 25mg once per day

Treatment groups

40 Participants
are divided into 2 treatment groups

Locations

1
Prince of Wales Hospital. The Chinese University of Hong Kong Hong Kong Hong Kong

Sponsors and collaborators

Chinese University of Hong Kong

Lead sponsor